Divestments

Aldevron

The leading global supplier of plasmid DNA used in cell and gene therapies.

Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA.

Key Facts

Sector: Healthcare
Country: United States
Fund: EQT VIII
Entry: 2019
Exit: 2024
Website: Aldevron
Responsible Advisor: Eric Liu

About Aldevron

Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. The company’s mission is to develop and manufacture biologics at the highest quality that help make meaningful changes worldwide, and its custom development and manufacturing capabilities enable scientists to develop groundbreaking new therapies. Aldevron is based in Fargo, North Dakota and has additional operations in Madison, Wisconsin and Freiburg, Germany. The Company serves leading academic and research institutions, pharmaceutical and biotechnology companies.